Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Surgery Partners, Inc. - Common Stock (NQ:SGRY)

21.96 -0.18 (-0.84%)
Streaming Delayed Price Updated: 11:48 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surgery Partners, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
3 Stocks Under $50 in the Doghouse
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal
Chairman of the Independent Committee, Brent Turner, said the best path forward for Surgery Partners is to continue operating as an independent publicly traded company. 
Via Stocktwits
Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent
Surgery Partners rejects Bain Capital's acquisition bid, citing greater long-term value as a public company with strong growth potential and strategic plans. 
Via Benzinga
Earnings Scheduled For May 12, 2025
Via Benzinga
Key Takeaways From Surgery Partners Analyst Ratings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
SGRY Q1 Earnings Call: Volume Growth and Business Mix Shape Outlook Amid Margin Pressures
Healthcare company Surgery Partners (NASDAQ:SGRY) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 8.2% year on year to $776 million. Its non-GAAP profit of $0.04 per share was... 
Via StockStory
Topics Economy World Trade
3 Russell 2000 Stocks with Mounting Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
Assessing Surgery Partners: Insights From 4 Financial Analysts
Via Benzinga
Q1 Earnings Highlights: Surgery Partners (NASDAQ:SGRY) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of Surgery Partners (NASDAQ:SGRY) and its peers as we unravel the now-completed Q1 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
Surgery Partners Misses Q1 Marks But Sticks To 2025 Outlook
Surgery Partners reported Q1 revenue of $776 million and earnings of 4 cents per share, reaffirming its 2025 guidance despite missing analyst expectations. 
Via Benzinga
Surgery Partners (NASDAQ:SGRY) Posts Q1 Sales In Line With Estimates But Stock Drops
Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.2% year on year to $776 million. The company’s outlook for the full year was close... 
Via StockStory
Surgery Partners (SGRY) Q1 Earnings: What To Expect
Healthcare company Surgery Partners (NASDAQ:SGRY) will be reporting results tomorrow morning. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
3 Cash-Producing Stocks That Concern Us
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
3 Healthcare Stocks with Mounting Challenges
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth.... 
Via StockStory
Topics Economy Government World Trade
Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Encompass Health (NYSE:EHC) and its peers. 
Via StockStory
Topics Artificial Intelligence
Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at outpatient & specialty care stocks,... 
Via StockStory
Topics Artificial Intelligence
Q4 Earnings Outperformers: DaVita (NYSE:DVA) And The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
3 Reasons SGRY is Risky and 1 Stock to Buy Instead
What a brutal six months it’s been for Surgery Partners. The stock has dropped 29.9% and now trades at $21.10, rattling many shareholders. This might have investors contemplating their next move. 
Via StockStory
Topics Bankruptcy
Q4 Earnings Highs And Lows: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of agilon health (NYSE:AGL) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.5% year on year to $864.4 million. The company expects the full year’s revenue... 
Via StockStory
Earnings Scheduled For March 3, 2025
Via Benzinga
Surgery Partners (SGRY) Q4 Earnings Report Preview: What To Look For
Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results tomorrow before market open. Here’s what you need to know. 
Via StockStory
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Harmonic Issues Weak Guidance, Joins Fluence Energy, Amkor Technology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners... 
Via Benzinga
Royal Caribbean Cruises Posts Upbeat Earnings, Joins Brighthouse Financial, Invesco, Boeing And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.